Heart Protection by Combination Therapy with Esmolol and Milrinone at Late-Ischemia and Early Reperfusion
2011
Introduction
The present study determined whether late-ischemia/early reperfusion therapy with the β1-adrenergic receptor (AR) blocker esmolol and phosphodiesterase III inhibitor milrinone reduced left ventricular (LV) myocardial infarct size (IS).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
28
References
20
Citations
NaN
KQI